Best Doctors in Spain — Get an Online Consultation

Professional Resume

Basic education

• Electronic Engineering , Buenos Aires (1984)
• Physics of Radiotherapy , National Atomic Energy Commission of Argentina (CNEA, 1984)
• Master of Medical Physics , Universities of Toulouse and Paris (1986)
• Doctor of Science in Medical Physics , Universities of Toulouse and Paris (1990, Stereotactic Radiotherapy)

Publications

• Scientific index: 36.93
• Number of publications: 140

Professional activity

• 1980-1984 – Lecturer, University of Buenos Aires
• 1982-1984 – Academy of National Medicine of Argentina
• 1985-2018 – Institut Curie (Paris)
  • Latest positions:
    • Technical Director of the Proton Therapy Center
    • Head of the Department of Medical Physics

Research Internships as a Visiting Professor

• 2003-2004 – Massachusetts General Hospital & Harvard Medical School (Boston, USA)
• 1998 – Indiana University Cyclotron Facility (Bloomington, USA)

Membership in scientific committees

• 2014 – CERN International Strategy Committee for Medical Applications
• 2000 – Conseil Scientifique National de Hadrontherapie (France)
• 2012 – The Belgian Hadrontherapy Center Foundation
• Scientific and expert consultant for companies: IBA, IBA Dosimetry, Varian Particles, Siemens, Tomotherapy
• Scientific advisor at proton therapy centers in various countries:
  • China (Wanjie)
  • South Africa (Cape Town)
  • USA (Indiana, New York)
  • Italy (Trento)
  • South Korea (Seoul)
  • France (Caen)
  • Netherlands (Maastro)
  • Argentina (Buenos Aires)
  • Austria (MedAustron)
• Member of the Scientific Council at the Embassy of Argentina in France

Reviewing articles for scientific journals

• Physics in Medicine and Biology
• Medical Physics
• Physics Medicine
• Radiotherapy and Oncology
• Radiation Protection Dosimetry
• Radioprotection
• Cureus and others

Membership in scientific societies

• PTCOG (Particle Therapy Cooperative Group) – Chairman (2010-2013)
• ESTRO (European Society for Radiotherapy and Oncology)
• SFPM (Société Française de Physique Médicale)
• PMSF (Physiciens Médicaux Sans Frontières)

Teaching activities

• Master's program "Medical Physics" , Faculty of Medicine, University of Paris-Sud
• School of Proton Therapy ESTRO
• PTCOG Educational Master Classes
• Inter-University Diploma in High-Tech Radiotherapy
• Diploma in Radiation Biology and Radiation Protection in Radiotherapy (France)
• AAPM Summer School , Colorado Springs, USA (2015)
• Scientific supervision of postgraduate students, masters students, interns (up to 10 students per year)
• Invited lectures in various countries around the world (about 10 per year)

Grants and funding received (more than €50 million)

1. MIGAC – New Proton Therapy Centre of the Institut Curie
2. Grant Canceropole
   • (a) Targeted proton therapy for pediatric and adult tumors: technical optimization, radiobiology, socioeconomic assessment
   • (b) Dynamic proton therapy
3. Grant Physician – DEDIPRO (development of a new diamond detector and fast radiation therapy planning system for pulsed proton beams)
4. Industrial and regional grants – Areva 1-2-3, Feder, Varian, etc.
5. European Commission Grants
   • INFRAIA-02-2017 – INSPIRE (Infrastructure for International Proton Therapy Research)
6. IDEX Paris-Saclay – NanoTheRad (research on nanoparticles in medicine)

This specialist has made significant contributions to the development of proton therapy, radiation oncology and medical physics, combining scientific research, teaching and work at the world's leading medical and research institutions.

Chief of Internal Medicine | Medical Educator | Researcher
Location: Torrevieja, Valencian Community, Spain
Languages: Spanish (native), English (fluent)

Professional Experience

🔹 Head of Internal Medicine Department
Quirónsalud, Torrevieja
June 2023 – Present (1 year 10 months)

Leading the Internal Medicine Department at Quirónsalud Hospital in Torrevieja.

Overseeing clinical strategy, patient care, and departmental coordination.

Mentoring junior physicians and contributing to medical education and research.

🔹 Specialist in Internal Medicine
Quirónsalud, Torrevieja
July 2020 – September 2023 (3 years 3 months)

Provided high-quality care in internal medicine with a focus on complex clinical cases.

Participated in multidisciplinary teams and collaborated on patient management strategies.

Actively involved in teaching and academic activities.

🔹 Specialist in Internal Medicine
Hospital de Manacor, Balearic Islands
May 2019 – July 2020 (1 year 3 months)

Delivered comprehensive internal medicine services in a regional hospital setting.

🔹 Head of Internal Medicine Department
Hospital General de Villalba, Madrid – Quirónsalud Group
June 2014 – May 2019 (4 years 11 months)

Directed the Internal Medicine Department of a large general hospital in Madrid.

Developed protocols and care pathways, and played a key role in hospital management.

Engaged in teaching as an Associate Professor at Universidad Europea de Madrid (2018–2020).

🔹 Specialist and Head of Internal Medicine
Ribera Salud, Elche (Alicante)
Head of Internal Medicine: Jan 2010 – Dec 2012
Specialist in Internal Medicine: Jan 2012 – Feb 2014

Led the department and managed a multidisciplinary medical team.

Continued as a staff internist with a focus on patient care and chronic disease management.

🔹 Specialist in Internal Medicine
Hospital San Jaime, Torrevieja
May 2002 – Jan 2010 (7 years 9 months)

Provided specialized care in internal medicine in both inpatient and outpatient settings.

Academic & Teaching Experience

🔹 Associate/Guest Professor
CEU Cardenal Herrera University, Elche
2020 – 2023

Taught courses in Internal Medicine and supervised research projects.

Promoted evidence-based medicine and clinical reasoning among medical students.

🔹 Associate Professor
Universidad Europea de Madrid
2018 – 2020

Lectured in internal medicine and clinical practice for medical students.

Participated in academic development and evaluation committees.

Skills & Areas of Expertise

Internal Medicine

Hospital Leadership & Management

Medical Education & Training

Research & Development

Chronic Disease Management

Multidisciplinary Collaboration

Highly qualified medical doctor since 2000

Being a medical doctor, is able to assess your needs, advise you and meet your expectations in a professional and safe manner. 

Dr Maria is recommended by top reviews and patient's testimonials.

EDUCATION AND QUALIFICATIONS 

Septmeber 2019                                                                                                           Basic life support 

August 2014 

MRCG General Practitioner       

January 2011 July 2010 

GP update course Hot topics BLS and AED 

Child protection certificate - level 1 Health and Safety Certificate Communication Skills RCGP Mini GP Update Course Hypertension in Primary Care ALS certificate 

August 2011                                                                                                                    FACD 5.2 certificate      

September 2000                                                                                                                 MB BS University of Medicine and Pharmacy Iasi, Romania 

PUBLICATIONS 

pg. 2 

Pg. 3 

Co-author 

March 2006 Cognitive Impairment in Elderly People with Systemic Lupus 

Erythematosus. 32th National Conference in Geriatric Medicine Resume Book. 20-22 Oct 2005 

Sept 2000 

The influence of a substance S6 over the non-specific defence system co-author Department of Pharmacology, Gr T Popa University, Iasi, Romania

Dr. Karin P. Q. Oomen, MD PhD

Consultant ENT Surgeon

www.andsurgeons.com

Date of Birth: 13 August 1977

Education

Biology, University of Utrecht — Sep 1995 – Sep 1996

Doctoral Degree in Medicine, University of Utrecht — Sep 1996 – Dec 2001

M.D., School of Medicine, University of Utrecht — Dec 2001 – Dec 2003

Senior House Officer, ENT Surgery, UMC Utrecht — Aug 2004 – Jan 2006

Residency, ENT Surgery, UMC Utrecht/Wilhelmina Children's Hospital — Feb 2006 – Feb 2011

PhD, Dept. of Anatomy & ENT Surgery, University of Utrecht — Feb 2011 – May 2011

Thesis: Anatomical and clinical appraisal of the pterygopalatine ganglion. Defended: 27 May 2011

Certifications

United States: ECFMG Certification — 1 May 2012

United States: Medical Licencing Examination (USMLE) — 1 May 2012

Step I: 203/84

Step IIa – Clinical Knowledge: 223/80

Step IIb – Clinical Skills: Pass

Surgical Fellowship

Paediatric Otolaryngology, Weill Cornell Medical College, New York, USA — Aug 2011 – Aug 2013

Professional Experience

Current Positions (since 2022)

Consultant ENT Surgeon & Owner, ANDSURGEONS, Andorra

Consultant ENT Surgeon, Clínica Omega Zeta & Clínica Som Salut, Andorra

Consultant ENT Surgeon, Centro Medico Teknon (Barcelona) Spain, Juaneda Clinics, Menorca, Spain, Avantmedic (Lleida), Spain

Consultant ENT Surgeon, Medinet, Portland Clinical, Imperial College London (Honorary Contract)

Previous Roles

Paediatric Otolaryngologist, UMC Utrecht/Wilhelmina Children’s Hospital — Feb 2014 – Feb 2016

Specialized in pediatric and adult ENT, with specific focus on voice, airway, cleft palate and laryngotracheal surgery.

Consultant ENT Surgeon, Queen Alexandra Hospital, Portsmouth, UK — Sep 2017 – December 2020

Licensure

United Kingdom: GMC #7511829 – Fully Registered, Specialist Registration

Netherlands: BIG #49061371701 – Physician (since Dec 2023)

Netherlands: RGS #1910932 – Otolaryngologist (since Feb 2011)

Spain: COMB #65907 (Barcelona)

Andorra: RPS #03255, Collegiat #913

Languages

Dutch: Native

English: Full Professional Proficiency

Spanish: Professional Working Proficiency

German: Professional Working Proficiency

French: Professional Working Proficiency

Catalan: Limited working proficiency

Medical Missions

Cleft lip and palate repair, Antigua, Guatemala — MMFC — Jun 2012

Selected Publications

Full list available at: https://pubmed.ncbi.nlm.nih.gov/?term=Oomen+k&sort=date

1. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.

Oomen KP, Paramasivam S, Waner M, Niimi Y, Fifi JT, Berenstein A, O TM. 

Laryngoscope. 2016 Jan;126(1):205-11.

2. Thyroglossal duct cyst and ectopic thyroid: surgical management.

Oomen KP, Modi VK, Maddalozzo

J.Otolaryngol Clin North Am. 2015 Feb;48(1):15-27.

3. Epiglottopexy with and without lingual tonsillectomy.

Oomen KP, Modi VK.

Laryngoscope. 2014 Apr;124(4):1019-22.

4. Evidence-based practice: pediatric tonsillectomy.

Oomen KP, Modi VK, Stewart MG. 

Otolaryngol Clin North Am. 2012 Oct;45(5):1071-81

5. Effect of adenotonsillectomy on middle ear status in children.

Oomen KP, Rovers MM, van den Akker EH, van Staaij BK, Hoes AW, Schilder AG.

Laryngoscope. 2005 Apr;115(4):731-4.

Dr. Pierluigi Minicozzi is a certified Hatha Yoga Instructor. He received his accreditation from Alliance Yoga in Rishikesh, India, in 2019. He has taught widely in Italy and Spain. He leads sessions at festivals and retreat centers.

Dr. Minicozzi brings together different spiritual traditions and holistic practices in his classes. He focuses on helping students align their body, mind, and emotions. His teaching aims to support self-awareness and well-being. He is dedicated to providing transformative yoga education.

Objective
I am a dedicated and empathetic psychologist with a passion for working with individuals who have undergone difficult life experiences, particularly trauma. After completing my degree in psychology in 2018, I have continued to develop my expertise through further education and hands-on experience. I am seeking an opportunity to contribute my knowledge and skills to help individuals recover and improve their mental well-being.

Education

Master’s Degree in Psychology
I completed my master’s degree in psychology in 2018, and during my studies, I developed a strong interest in trauma psychology and mental health. My theoretical education has been complemented with practical experience in various fields of psychology, providing me with a broad understanding of the factors that affect mental health.

Continuing Education and Courses in Trauma and Mental Health
Over the past few years, I have continued to deepen my knowledge and specialize in trauma treatment and psychological conditions such as anxiety, depression, and PTSD. Some of the courses I have completed include:

• Trauma-Informed Therapy (TIT)
• Cognitive Behavioral Therapy (CBT) for Trauma
• Psychological First Aid
• Mindfulness and Psychological Treatment

Professional Experience

Psychologist, Psychiatric Department of the Military Medical Academy
One of my most significant experiences was working in the psychiatric department of the Military Medical Academy, where I worked with clients dealing with various forms of trauma, especially from military service in conflict zones. During my time there, I worked both individually and in groups with traumatized soldiers and civilian patients who had experienced psychiatric disorders resulting from severe experiences.

I was responsible for assessing, diagnosing, and treating mental health conditions such as PTSD, depression, anxiety, and emotional instability. Treatments included Cognitive Behavioral Therapy (CBT), psychoeducation, and trauma-focused therapy. I quickly learned to adapt my methods depending on the individual’s specific needs, which was an invaluable lesson in understanding the complex psychological effects of trauma.

Key Responsibilities:

• Conduct psychological assessments and diagnostic interviews.
• Treat and support patients with trauma and mental health disorders through both individual and group therapy.
• Develop and implement treatment plans for long-term rehabilitation.
• Provide support to patients and their families, helping them understand and manage the effects of trauma.
• Actively participate in interdisciplinary collaboration with doctors, nurses, and other therapists to ensure holistic care for patients.

Psychologist, Private Practice
In addition to my role at the Military Medical Academy, I have also run a private practice where I have worked with a broader client group, including individuals seeking help for stress, anxiety, depression, relationship issues, and work-related difficulties. I have applied both CBT and other evidence-based methods to help patients process their emotions and improve their mental health.

Key Responsibilities:

Conduct individual psychological assessments and treat patients for various mental health issues. Provide counseling and support to patients dealing with life-changing events such as separation, loss, or career transitions.

• Educate and support patients in coping strategies and stress management techniques.

Skills and Competencies

• Trauma-Focused Therapy – Experience in treating individuals who have undergone severe trauma, including PTSD and other stress-related conditions.
• Cognitive Behavioral Therapy (CBT) – Strong expertise in using CBT to treat anxiety, depression, and other mental health conditions.
• Group Therapy – Experience in facilitating support groups for individuals with similar experiences, especially in military and trauma-based contexts.
• Psychological Assessment and Diagnosis – Proficient in conducting psychological evaluations and assessments to identify underlying mental health issues.
• Empathy and Active Listening – Excellent ability to create a safe and open environment where patients feel heard and supported.
•  

Languages

• Bulgarian: Native
• English: Fluent in both spoken and written communication
• Spanish: Fluent in both spoken and written communication.

CURRICULUM VITAE

VOLKERT B. WREESMANN MD PhD

Consultant Otolaryngologist

Oncologic Head and Neck Surgeon

Thyroid and Parathyroid Surgeon

Facial Plastic Surgeon

Principal Positions

• Centro Medico Teknon, Barcelona, Spain

Chairman, Department of Otolaryngology-Head and Neck Surgery

July 1st 2024 – present

• Juaneda, Ciutadella Menorca, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

January 2025 – present

• Avantmedic, Lleida, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

July 1st 2024 – present

• Clinica Omega Zeta, Andorra

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2022 – present

• University Hospitals Dorset NHS Foundation Trust

Consultant Otolaryngologist-Head and Neck Surgeon

August 1st 2021 – October 1st 2023

• Oxford University Hospitals NHS Foundation Trust

Honorary Consultant Otolaryngologist-Head and Neck Surgeon

May 1st 2021 – April 30th 2024

• Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Consultant Otolaryngologist-Head and Neck Surgeon

July 18th 2016 – April 30th 2021

• Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Consultant Otolaryngologist-Head and Neck Surgeon

November 7th 2015 – May 31st 2016

• Heart of England NHS Trust, Birmingham, UK

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2015 – October 31st 2015

• University Medical Center Utrecht, Netherlands

Consultant Otolaryngologist-Head and Neck Surgeon

November 1st 2013 – June 1st 2014

Memberships

• American Head and Neck Society – Member

Netherlands Academy of Otolaryngology - Member

Professional Licences

• United Kingdom

GMC Certification

Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

Registered: 02/02/2015

GMC # 7499626

• United States of America

New York State Department of Health

New York State Education Department

Registered: July 2011

License# P80949

Physician

• Netherlands

Dutch Ministry of Health (BIG Registration)

BIG Registered: 22-06-2005

BIG #19063373601

Physician

Dutch Specialist Board (RGS)

RGS registered: 01-02-2011

RGS #1911979

Otolaryngology-Head and Neck Surgeon

• Spain

Collegi de Metges de Barcelona

COMB: 63638

• Andorra

Collegi de Metges d’Andorra

RPS: 03098

COMA: 876

Education

• Memorial Sloan-Kettering Cancer Center

Surgical Fellowship, Head and Neck Surgery

New York, New York, USA

August 1st 2011 - July 31st 2013

600 bed dedicated cancer center

Performed 1200 major oncologic head and neck resections in 2 years

• United States of America ECFMG Certification

United States Medical Licensing Examination (USMLE)

Certification: June 22nd, 2010

Scores: 

   Step I: 244/99 

   Step IIa-Clinical knowledge: 227/94

   Step IIb-Clinical Skills: PASSED

   Step III: 206/85

• Netherlands Cancer Institute

Surgical Fellowship, Head and Neck Surgery

Amsterdam, The Netherlands

February 1st 2011 - July 31st 2011

Specialized Head and Neck Cancer Surgery Department

200 bed hospital

• Amsterdam University Medical Center/Netherlands Cancer Institute

Residency Training, Otolaryngology-Head and Neck Surgery

Amsterdam, the Netherlands

February 1st 2006 – January 31st 2011

• University of Amsterdam School of Medicine

Medical Doctor (MD)

Amsterdam, the Netherlands

December 2002 - January 28th 2005

• University of Amsterdam

Doctor of Philosophy (PhD), Molecular Biology

Amsterdam, the Netherlands

Thesis title: Molecular-cytogenetic characterization of head and neck cancer

December 2nd, 2004

• Erasmus University School of Medicine

Doctoral Degree in Medicine

Rotterdam, the Netherlands

September 1994 - November 17th, 1998

Research Training

• Memorial Sloan-Kettering Cancer Center

Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

Research Fellowship in Molecular Oncology

Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

March 1st 1999 - September 30st 2002

• University of California San Francisco (UCSF)

Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

Post-doctoral Research Fellowship in Head and Neck Oncology

Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

February 2005 - January 2006

Academic Activities

University of Amsterdam

Doctorate Examination Committee member

• September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
• October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
• November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
• December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
• January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
• June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

Conference Faculty

• Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
• Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
• Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

Editorial Roles

• European Journal of Surgical Oncology

Associate Editor

January 1st 2023 – present

• European Journal of Surgical Oncology

Guest Editor

March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

• Journal of Oral Pathology and Medicine

Guest Editor

November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

• Scientific Journal Reviewer

Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

• Scientific Project and Grant Reviewer

Netherlands: Dutch Cancer Society

France: Institute National du Cancer

Awards

• New York Head and Neck Society

Annual Meeting, New York, NY, March 2002

Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

Invited Lectures

• European Society of Surgical Oncology meeting, Krakow, 2016
• Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
• University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
• Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
• Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
• Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
• Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
• Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
• Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

Published Research Reports

• The growing precision of diagnostic pathways in thyroid nodule evaluation. 

Bekker J, Wreesmann VB. 

Eur J Surg Oncol. 2025 Jan;51(1):109374.

• Special issue: Management of vascular tumors and malformations of the head and neck. 

Oomen KPQ, Brennan PA, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):829.

• Angiosarcomas of the head and neck: Impact of large data analysis on clinical management.
•  
• Wreesmann VB, Oomen KP, Brennan PA.

J Oral Pathol Med. 2022 Nov;51(10):904-910.

• Current classification of vascular anomalies of the head and neck. 

Oomen KPQ, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):830-836.

• A novel classification of carotid body tumors.

Wreesmann VB, Nixon IJ. 

Eur. J. Surg. Oncol. May, 2021

• Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

Shaha AR, Tuttle RM, Wreesmann VB. 

Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

• Improvement of oral cancer screening quality and reach: The promise of artificial intelligence.
•  
• Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA.

J Oral Pathol Med. 2020 Mar 11

• The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

Ammar M, Wreesmann VB. 

Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

• Nasal obstruction secondary to an inverted midline supernumerary tooth. 

Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

Ann R Coll Surg Engl. 2019 Jan;101(1)

• Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

Oncotarget. 2018 Apr 6;9(26):18198-18213.

• Complete nasal obstruction secondary to pacemaker insertion. 

Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

Ann R Coll Surg Engl. 2018 May;100(5)

• Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

2018 Mar;44(3):276-285. Review.

• The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

Wreesmann VB; on behalf of EJSO. 

Eur J Surg Oncol. 2018 Mar;44(3):275.

• Aggressive differentiated thyroid cancer. 

Janjua N, Wreesmann VB. 

Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

• Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

Wreesmann VB. 

International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

• An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

Thyroid. 2016 Mar;26(3):373-80.

• Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
•  
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

• Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

Ann Surg Oncol. 2015 Jul 28.

• Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
•  
• Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 May;25(5):503-8.

• Head and neck squamous cell carcinoma in young patients.

van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

Oral Oncol. 2013 Dec;49(12):1097-102.

• Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

Head Neck. 2013 Jan;35(1):94-102.

• Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

Oral Oncol. 2010 Nov;46(11):780-5.

• Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap.

Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

Head Neck. 2009 Jun;31(6):838-42.

• Clinical impact of molecular analysis on thyroid cancer management.

Wreesmann VB, Singh B. 

Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

• Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.

Wang SJ, Wreesmann VB, Bourguignon LY. 

Head Neck. 2007 Jun;29(6):550-8.

• Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
•  
• Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ.

ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

• Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
•  
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
•  
• Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

• Repetitive endoscopic sinus surgery failure: a role for radical surgery?

Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

• MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.
•  
• Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B.
•  
• Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

• Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.

Wreesmann VB, Singh B. 

J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

• Molecular profiling of tumor progression in head and neck cancer.
•  
• Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G.
•  
• Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

• Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

J Clin Oncol. 2004 Oct 1;22(19):3965-72.

• Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

• Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

Cancer Res. 2004 Jun 1;64(11):3780-9.

• Genetic abnormalities associated with nodal metastasis in head and neck cancer.

Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

Head Neck. 2004 Jan;26(1):10-5.

• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
•  
• Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.
•  
• J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

• Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

• Genome-wide appraisal of thyroid cancer progression.
•  
• Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B.
•  
• Am J Pathol. 2002 Nov;161(5):1549-56.

• Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure.
•  
• Wreesmann VB, Fokkens WJ, Knegt PP.
•  
• Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

• Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.
•  
• Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ.
•  
• Histopathology. 2001 Feb;38(2):105-10.

• Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
•  
• Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
•  
• Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

Abstracts (Presentations at scientific meetings):

• Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma.
•  
• Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B.

Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

• Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

• Gain of 1q is unique to the tall cell variant of papillary thyroid cancer.

Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

• MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

• Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

• p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

• Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

• Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

•  
• Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

• Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

• Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

• Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

Books, Chapters:

• Molecular Biology as applied to Head and Neck Oncology

Wreesmann VB, Singh B.

Stell and Maran's Textbook of Head and Neck Surgery and Oncology

Fifth Edition

Chapter, edited by John Watkinson and Ralph Gilbert

• Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

Wreesmann VB, Singh B.

Book, Amsterdam 2004

Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

• Open Conservation Surgery for Laryngeal Cancer

Wreesmann VB, Ganly I

Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

Chapter 27

CRC Press, Taylor-Francis Group, June 12th, 2018

• Molecular Oncology

Wreesmann V.B.

Self-Assessment in Head and Neck Surgery and Oncology, First Edition

Chapter 21

Elsevier 2014

Research grants:

Netherlands Cancer Institute “Startgeld” Grant 2008

Project: Fanconi anemia in head and neck cancer

Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

Amount granted: 300.000 euro

Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.

She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.

Louise is a Certified Drug And Alcohol Addiction Counsellor (Practitioner Member of AP; ICADC; MBACP).

She has studied at The Westminster Pastoral Foundation (WPF); The Metanoia Institute; Bath University; and London South Bank University (LSBU)..

Louise has a MSc. In Addiction Psychology And Counselling with Distinction (LSBU); a qualification in Interpersonal Group Therapy (Action On Addiction); and a certificate in Schema Therapy (The Institute Of Schema Therapy, London).

Louise’s practice is trauma-informed and she is currently working towards certification as an EMDR therapist.
She has worked in addiction treatment centres since 2009, both in Spain and the UK.

Louise is passionate about supporting others to develop connection and mean in their lives.

A fully qualified Integrative Counsellor and Psychotherapist with a background in Coaching Psychology and over 10 years of experience working with people with diverse needs. A pre-accreditated member of the Irish Association of Counselling & Psychotherapy and an accredited member of the Association for Coaching. Compassionate listener, empathic, self-motivated, creative, honest and resilient individual with an array of transferable skills. Seeking new opportunities where I can utilize my skillset in the delivery of mental health care treatment services.

As an Integrative Therapist, she has experience working with individuals and groups presenting with a diversity of mental health difficulties. Her training provides her with a variety of theoretical frameworks that allow her to tailor her work to meet the needs of each client; including but not limited to Person-Centred Therapy, Transactional Analysis, Internal Family Systems, Choice Theory, Coaching and Mindfulness. She provides a safe, authentic therapeutic space to support clients in finding healthy ways of coping with emotional, personal, social, and psychological difficulties.

A traumatologist and orthopedic surgeon based in Madrid with nearly 30 years of experience. Throughout his extensive career, he has specialized in the diagnosis and treatment of knee joint pathologies, shoulder joint conditions, sports injuries, ankle disorders, knee joint prosthetics, robotic surgery, and knee trauma.

Graduated from the Faculty of Medicine and Surgery at the University of Navarra, specializing in Orthopedic Surgery and Traumatology at the same institution. Additionally, he earned a doctorate in Medicine and Surgery. Based on the MIR rankings, he was recognized as the resident with the best resume in Spain across all specialties.

Later, he pursued advanced training in shoulder surgery in California and completed internships at ten hospitals in the UK and the USA, including the Mayo Clinic in Rochester, as well as the universities of Miami, Oxford, and Cambridge.

Throughout his professional career, he has served as a medical consultant for various clinics and centers, as well as for professional teams such as the Cleveland Cavaliers (NBA), Cleveland Browns (NFL), and Cleveland Indians (baseball). Additionally, he has worked as a trauma consultant for several football teams, including Atlético Madrid, Getafe, and Real Zaragoza, and has collaborated with Spanish federations for gymnastics, judo, and karate.

**Experience**  

- Director of Rights, Partnerships, and Colors at Olympia Quironsalud.  

- Orthopedic Surgery and Traumatology residency through MIR (rank 80) at the University Clinic of Navarra, Pamplona.  

- Clinical Fellow at the Orthopedic and Traumatology Department, University Clinic of Navarra, Pamplona.  

- Clinical Fellow at Cleveland Clinic Foundation, Cleveland.  

- Assistant Traumatologist at the Dexeus University Institute (ICATME), Barcelona.  

- Assistant Traumatologist at the Galicia Institute of Orthopedic Surgery and Sports Medicine (IGACOTDE), Hospital Santa Teresa, La Coruña.  

- Specialist in Traumatology at CEMTRO Clinic, Madrid.  

- Head of the Knee Department at FREMAP Hospital, Majadahonda.

CLINICAL ROTATIONS ABROAD

- University of Miami. Jackson Memorial Hospital. Florida, USA. 5 months  

- Kleinert Institute of Hand Surgery. Louisville, Kentucky, USA. 1 month  

- John Radcliffe Hospital. Oxford, England. 3 weeks  

- Nuffield Orthopaedic Centre. Oxford, England. 3 weeks  

- Mayo Clinic. Rochester, Minnesota, USA. 3 weeks  

- O'Connor Hospital. San Jose, California, USA. 3 weeks  

- Wellington Hospital. London, England. 1 week  

- Princess Grace Hospital. London, England. 1 week  

- Addenbrooke's Hospital. Cambridge, England. 2 weeks  

- BUPA Cambridge Lee Hospital. Cambridge, England. 2 weeks  

- Cleveland Clinic Foundation. Cleveland, Ohio, USA. 2.5 years  

- 2002. WPOA Scholarship (Australia, New Zealand, Singapore). 4 weeks  

- Orthopaedic Institute of Southern California, USA. 4 weeks

Qualification

- Higher education in medicine and surgery. University of Navarra  

- Doctor of Medicine. University of Navarra  

- Specialist in orthopedic surgery and traumatology. University of Navarra Clinic, clinical fellowship in sports medicine. Cleveland Clinic Foundation  

- Clinical fellowship in foot and ankle surgery. Cleveland Clinic Foundation  

- Diploma in English from the School of Official Languages. A Coruña  

- ECFMG (Educational Commission for Foreign Medical Graduates)

Memberships

- AEA (Spanish Arthroscopy Association)  

- SEROD (Spanish Society for Knee Problems)  

- SECOT (Spanish Society of Orthopedic Surgery and Traumatology)  

- ESSKA (European Society of Sports Traumatology, Knee Surgery, and Arthroscopy) – International Society of Arthroscopy, Knee Surgery, and Orthopedic Sports (ISAKOS)  

- WARTHOG Orthopedic Society  

- MAGELLAN Orthopedic Society – SOMACOT (Madrid Society of Orthopedic Surgery and Traumatology)  

- Fellows Society of the Barry de la Maza Foundation

Other Achievements

- Former board member of SEROD (Spanish Society for Knee Problems)  

- Former board member of AEA (Spanish Arthroscopy Association)  

- Former editor of the journal *Cuadernos de Arthroscocoy* (AEA)  

- President of the AEA-SEROD Joint Congress 2015, Madrid  

- Member of the Arthroscopy Committee of ESSKA (European Society of Sports Traumatology, Knee Surgery, and Arthroscopy)  

- Member of the ESSKA Research Group on Knee Collateral Ligaments  

- Honorary member of the Argentine Arthroscopy Association  

- Patron of the Maria Pagés Foundation and Choreographic Center

Doctor of Medicine with Bachelor's Degree in Physiology with added training in Psychiatry in the UK; to Associate Specialist level in Psychiatry for both Child and Adolescent,  as well as Adult Mental Health. Postgraduate  certificate in Education with Coaching and teaching qualification.

Dr Angelina is an  experienced Psychiatrist with 20+ Years in Mental Health with adults and  

children, specializing in PTSD and trauma related personality disorders. Exceptionally apt  

to Psychotherapy methods achieving proven results with her individual approach of a

Holistic Mental Health Care. 20 years of cross-cultural experience from living  

all over Central and Eastern Europe, as well as, in New Zealand and the UK.

Dr. Fernando Reyes is a specialist in sports physiotherapy and heads the Department of Physical Medicine and Rehabilitation at the Olympia Medical and Surgical Center.

With over 25 years of experience in prestigious organizations such as the Royal Spanish Basketball Federation, the Spanish Baseball Federation and Real Madrid Football Club, Dr. Reyes is a recognized expert in his field.

His primary goal is to provide high-quality care, typically reserved for elite athletes, to a wide range of patients at Olympia. Through a multidisciplinary approach and deep understanding of biological processes, he aims to optimize recovery and provide each athlete with the tools to achieve peak performance.

Experience

• -Head of the Physiotherapy Service at the Olympia Medical and Surgical Center.
• -Director of the Master's Program in Sports Physiotherapy and Rehabilitation at the Camilo José Cela University (UCJC).
• -President of the Spanish Athletic Training Association SATTA.
• - Physiotherapist of the football club Real Madrid (1997-2011).
• - Physiotherapist of the Royal Spanish Basketball Federation (1997-1999).
• - Physiotherapist of the Spanish Baseball Federation (1998).
• - External consultant for various professional football and basketball clubs.

Qualification

• -Degree in Physiotherapy.
• -Specialization in sports physiotherapy.
• -Master of Health Research.
• -Director of the Master's Program in Athletic Training and Therapy at UCJC.

Dr. Reyes actively collaborates with national and international athletes, offering rehabilitation and rehabilitative services aimed at restoring and improving athletic performance.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Dr. Aranda received his degree in Medicine and Surgery from the Universidad de Málaga in 1983. He specialized in traumatology and orthopedics at the Department of Traumatology and Surgical Orthopedics of the Instituto Dexeus, Barcelona between 1988 and 1993. under the direction of Dr. Villarrubias.

Throughout his medical practice, Dr.Aranda has worked in leading hospitals in Spain, participated in the medical support of the 1992 Olympics in Barcelona and was a traumatologist in the Federación Española de Motociclismo in the European and World Championships in the period 1982 - 1992.

Dr. Aranda currently concentrates his medical practice on the treatment of pathologies of the hip and foot at Hospital Quironsalud Marbella and is a traumatologist at the Sociedad Sportclinic Marbella, a member of the Spanish Society for Hip Surgery Secca.